Zhejiang Canaan Technology Limited (300412.SZ)
CNY 5.31
(0.38%)
CNY 5.31
(0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -53.64 Million | 68.61 Million | 75.02 Million | 55.46 Million | 41.5 Million | -21.61 Million |
| Net Income | -23.43 Million | -83.44 Million | 87.64 Million | 77.45 Million | 58.98 Million | 45.82 Million |
| Depreciation & Amortization | 47.62 Million | 36.38 Million | 33.64 Million | 21.9 Million | 19.86 Million | 16.92 Million |
| Deferred income taxes | -74.81 Thousand | -6.21 Million | -1.08 Million | -758.58 Thousand | 4.14 Million | -2.32 Million |
| Stock-based compensation | - | - | - | - | -5.51 Million | 3.75 Million |
| Change in working capital | -127.31 Million | -3.91 Million | -48.14 Million | -64.42 Million | -53.17 Million | -111.75 Million |
| Other non-cash items | 271.46 Million | 119.58 Million | 1.88 Million | 20.53 Million | 17.19 Million | 27.39 Million |
| Investing Cash Flow | -138.1 Million | -283.26 Million | -82.01 Million | -96.58 Million | -42.91 Million | 34.57 Million |
| Investments in PPE | -164.89 Million | -165.69 Million | -154.87 Million | -81.49 Million | -17.34 Million | -52.18 Million |
| Acquisitions | 1.79 Million | 8.84 Million | -12.44 Million | -10.41 Million | -8.7 Million | 40.82 Thousand |
| Investment purchases | -190 Million | -330 Million | 12.44 Million | -200 Million | -230 Million | -320 Million |
| Sales/Maturities of investments | 215 Million | 212.32 Million | 72.15 Million | 184.43 Million | 203.24 Million | 402 Million |
| Other Investing Activities | 6 Million | -8.73 Million | 701.77 Thousand | 10.9 Million | 9.89 Million | 86.75 Million |
| Financing Cash Flow | 128.62 Million | -13.96 Million | 231.48 Million | 37.09 Million | -28.16 Million | 28.27 Million |
| Debt repayment | -151.29 Million | -153.37 Million | -237 Million | -89.34 Million | -64.97 Million | -69 Million |
| Dividends payments | -11.04 Million | -17.56 Million | -41.15 Million | -40.82 Million | -28.06 Million | -30.71 Million |
| Common Stock Repurchased | - | - | - | -8.65 Million | -13.67 Million | -2.05 Million |
| Common Stock Issuance | - | - | - | 8.65 Million | 13.67 Million | - |
| Other Financing Activities | -12.03 Million | 178.58 Million | 514.1 Million | 172.56 Million | 69.3 Million | 127.98 Million |
| Accounts receivables | 38.54 Million | -138.02 Million | -94.98 Million | -65.66 Million | -80.07 Million | -118.76 Million |
| Accounts payables | 9.32 Million | 270.96 Million | 165.3 Million | 120.23 Million | 127.99 Million | 103.83 Million |
| Inventory | -174.53 Million | -130.64 Million | -117.38 Million | -118.23 Million | -105.24 Million | -94.49 Million |
| Other working capital | -648.12 Thousand | -6.21 Million | -1.08 Million | -758.58 Thousand | 4.14 Million | -17.25 Million |
| Cash at beginning of period | 390.43 Million | 453.59 Million | 229.3 Million | 233.2 Million | 262.52 Million | 221.04 Million |
| Cash at end of period | 295.12 Million | 224.6 Million | 453.59 Million | 229.3 Million | 233.2 Million | 262.52 Million |
| Capital Expenditure | -164.89 Million | -165.69 Million | -154.87 Million | -81.49 Million | -17.34 Million | -52.18 Million |
| Effect of forex changes on cash | -481.26 Thousand | -379.57 Thousand | -200.82 Thousand | 114.68 Thousand | 252.4 Thousand | 254.3 Thousand |
| Net cash flow / Change in cash | -95.3 Million | -228.99 Million | 224.29 Million | -3.9 Million | -29.31 Million | 41.48 Million |
| Free Cash Flow | -218.54 Million | -97.07 Million | -79.84 Million | -26.02 Million | 24.15 Million | -73.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.12 Million | 17.93 Million | -5.98 Million | -23.43 Million | -46.28 Million | 6.25 Million |
| Depreciation & Amortization | - | 13.71 Million | 13.71 Million | 47.62 Million | 14.03 Million | -18.37 Million |
| Deferred income taxes | - | - | - | -74.81 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -90.2 Million | - | -127.31 Million | -136.64 Million | 93.04 Million |
| Other non-cash items | 1.43 Million | 59.78 Million | -75.9 Million | 271.46 Million | 184.42 Million | -85.74 Million |
| Investing Cash Flow | -10.8 Million | -13.34 Million | -22 Million | -138.1 Million | -66.55 Million | -54.36 Million |
| Investments in PPE | -10.88 Million | -10.44 Million | -23.04 Million | -164.89 Million | -62.8 Million | -55.79 Million |
| Acquisitions | 2.46 Million | 100 Thousand | 1.04 Million | 1.79 Million | 251.11 Thousand | 18.85 Thousand |
| Investment purchases | - | -98 Million | -15 Million | -190 Million | - | -95 Million |
| Sales/Maturities of investments | 17.31 Thousand | 95 Million | 15 Million | 215 Million | - | 96.41 Million |
| Other Investing Activities | 64.28 Thousand | -1.52 Million | 319.66 Thousand | 6 Million | -3.99 Million | -6209.94 |
| Financing Cash Flow | -18.85 Million | 5.68 Million | 49.84 Million | 128.62 Million | 45.85 Million | 49.68 Million |
| Debt repayment | -12.02 Million | -11.18 Million | -62.59 Million | -151.29 Million | -49.98 Million | -14.99 Million |
| Dividends payments | -4.59 Million | -3.32 Million | -3.64 Million | -11.04 Million | -2.96 Million | -3.19 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.24 Million | -2.05 Million | -12.74 Million | -12.03 Million | 6.5 Million | 67.87 Million |
| Accounts receivables | - | -57.26 Million | - | 38.54 Million | 38.54 Million | -26.76 Million |
| Accounts payables | - | - | - | 9.32 Million | - | - |
| Inventory | - | -33.22 Million | - | -174.53 Million | -174.53 Million | 119.81 Million |
| Other working capital | - | 279.38 Thousand | - | -648.12 Thousand | -648.12 Thousand | - |
| Cash at beginning of period | 163.56 Million | 230.9 Million | 295.12 Million | 390.43 Million | 307.96 Million | 175.42 Million |
| Cash at end of period | 138.43 Million | 298.38 Million | 230.9 Million | 295.12 Million | 295.12 Million | 166.09 Million |
| Capital Expenditure | -10.88 Million | -10.44 Million | -23.04 Million | -164.89 Million | -62.8 Million | -55.79 Million |
| Effect of forex changes on cash | -15.01 Thousand | 107.34 Thousand | 154.1 Thousand | -481.26 Thousand | 73.38 Thousand | 157.14 Thousand |
| Net cash flow / Change in cash | -25.12 Million | 67.48 Million | -64.21 Million | -95.3 Million | -12.84 Million | -9.33 Million |
| Free Cash Flow | -6.31 Million | 53.55 Million | -104.94 Million | -218.54 Million | -47.27 Million | -60.6 Million |
LIAB
OSB
AUMN
OPTOMED
AN3PJ
3689